These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 21269298

  • 1. Frovatriptan as preemptive treatment for fasting-induced migraine.
    Latsko M, Silberstein S, Rosen N.
    Headache; 2011 Mar; 51(3):369-374. PubMed ID: 21269298
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
    Silberstein SD, Elkind AH, Schreiber C, Keywood C.
    Neurology; 2004 Jul 27; 63(2):261-9. PubMed ID: 15277618
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine.
    Savi L, Mogavero S, Egan CG.
    Drug Des Devel Ther; 2014 Jul 27; 8():983-92. PubMed ID: 25092964
    [Abstract] [Full Text] [Related]

  • 4. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA, Brandes JL, Silberstein S, Jeka S, Czapinski P, Shaw B, Pawsey S.
    Headache; 2009 Oct 27; 49(9):1298-314. PubMed ID: 19788471
    [Abstract] [Full Text] [Related]

  • 5. Frovatriptan: a review of its use in the acute treatment of migraine.
    Sanford M.
    CNS Drugs; 2012 Sep 01; 26(9):791-811. PubMed ID: 22900951
    [Abstract] [Full Text] [Related]

  • 6. Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
    Silberstein SD, Berner T, Tobin J, Xiang Q, Campbell JC.
    Headache; 2009 Oct 01; 49(9):1283-97. PubMed ID: 19751371
    [Abstract] [Full Text] [Related]

  • 7. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
    Cady RK, Voirin J, Farmer K, Browning R, Beach ME, Tarrasch J.
    Headache; 2012 May 01; 52(5):749-64. PubMed ID: 22188311
    [Abstract] [Full Text] [Related]

  • 8. Frovatriptan for the acute treatment of migraine: a dose-finding study.
    Goldstein J, Keywood C, 251/96/14 Study Group.
    Headache; 2002 Jan 01; 42(1):41-8. PubMed ID: 12005274
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of two 6-day frovatriptan dosing regimens used for the short-term prevention of menstrual migraine: A phase I, randomized, double-blind, placebo-controlled, two-period crossover, single-centre study in healthy female volunteers.
    Wade A, Pawsey S, Whale H, Boyce M, Warrington S.
    Clin Drug Investig; 2009 Jan 01; 29(5):325-37. PubMed ID: 19366274
    [Abstract] [Full Text] [Related]

  • 10. Rapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label study.
    Spierings EL, Keywood C.
    Pain Med; 2009 Jan 01; 10(4):633-8. PubMed ID: 19453958
    [Abstract] [Full Text] [Related]

  • 11. Dose range-finding studies with frovatriptan in the acute treatment of migraine.
    Rapoport A, Ryan R, Goldstein J, Keywood C.
    Headache; 2002 Apr 01; 42 Suppl 2():S74-83. PubMed ID: 12028323
    [Abstract] [Full Text] [Related]

  • 12. Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies.
    MacGregor EA, Pawsey SP, Campbell JC, Hu X.
    Gend Med; 2010 Apr 01; 7(2):88-108. PubMed ID: 20435272
    [Abstract] [Full Text] [Related]

  • 13. Frovatriptan review.
    Markus F, Mikko K.
    Expert Opin Pharmacother; 2007 Dec 01; 8(17):3029-33. PubMed ID: 18001261
    [Abstract] [Full Text] [Related]

  • 14. Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severe.
    Cady R, Elkind A, Goldstein J, Keywood C.
    Curr Med Res Opin; 2004 Sep 01; 20(9):1465-72. PubMed ID: 15383196
    [Abstract] [Full Text] [Related]

  • 15. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan.
    Géraud G, Spierings EL, Keywood C.
    Headache; 2002 Apr 01; 42 Suppl 2():S93-9. PubMed ID: 12028325
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.
    Savi L, Omboni S, Lisotto C, Zanchin G, Ferrari MD, Zava D, Pinessi L.
    J Headache Pain; 2011 Dec 01; 12(6):609-15. PubMed ID: 21842274
    [Abstract] [Full Text] [Related]

  • 17. Clinical efficacy of frovatriptan: placebo-controlled studies.
    Ryan R, Géraud G, Goldstein J, Cady R, Keywood C.
    Headache; 2002 Apr 01; 42 Suppl 2():S84-92. PubMed ID: 12028324
    [Abstract] [Full Text] [Related]

  • 18. Extended cycle combined oral contraceptives and prophylactic frovatriptan during the hormone-free interval in women with menstrual-related migraines.
    Coffee AL, Sulak PJ, Hill AJ, Hansen DJ, Kuehl TJ, Clark JW.
    J Womens Health (Larchmt); 2014 Apr 01; 23(4):310-7. PubMed ID: 24450487
    [Abstract] [Full Text] [Related]

  • 19. Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks.
    Brandes JL, Poole Ac, Kallela M, Schreiber CP, MacGregor EA, Silberstein SD, Tobin J, Shaw R.
    Cephalalgia; 2009 Nov 01; 29(11):1133-48. PubMed ID: 19811503
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies.
    Mannix LK, Savani N, Landy S, Valade D, Shackelford S, Ames MH, Jones MW.
    Headache; 2007 Nov 01; 47(7):1037-49. PubMed ID: 17635595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.